184 related articles for article (PubMed ID: 18826487)
1. Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients.
Wetmore JB; Lovett DH; Hung AM; Cook-Wiens G; Mahnken JD; Sen S; Johansen KL
Nephrology (Carlton); 2008 Oct; 13(7):593-600. PubMed ID: 18826487
[TBL] [Abstract][Full Text] [Related]
2. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
3. Nutritional and inflammatory markers in the prediction of mortality in Chinese hemodialysis patients.
Hung CY; Chen YA; Chou CC; Yang CS
Nephron Clin Pract; 2005; 100(1):c20-6. PubMed ID: 15795516
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
5. Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.
Selim G; Stojceva-Taneva O; Zafirovska K; Sikole A; Gelev S; Dzekova P; Stefanovski K; Koloska V; Polenakovic M
Prilozi; 2006 Jul; 27(1):133-44. PubMed ID: 16985487
[TBL] [Abstract][Full Text] [Related]
6. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation].
Liang M; Wang L; Hou FF; Liu J; Liu ZQ; Tian JW
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896
[TBL] [Abstract][Full Text] [Related]
7. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients.
Kalantar-Zadeh K; Kopple JD; Humphreys MH; Block G
Nephrol Dial Transplant; 2004 Jun; 19(6):1507-19. PubMed ID: 15069177
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A: a biomarker for renal cancer.
Fischer K; Theil G; Hoda R; Fornara P
Anticancer Res; 2012 May; 32(5):1801-4. PubMed ID: 22593464
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory markers and in-hospital mortality in acute ischaemic stroke.
Rallidis LS; Vikelis M; Panagiotakos DB; Rizos I; Zolindaki MG; Kaliva K; Kremastinos DT
Atherosclerosis; 2006 Nov; 189(1):193-7. PubMed ID: 16388807
[TBL] [Abstract][Full Text] [Related]
10. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.
Zimmermann J; Herrlinger S; Pruy A; Metzger T; Wanner C
Kidney Int; 1999 Feb; 55(2):648-58. PubMed ID: 9987089
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid-A rather than C-reactive protein is a better predictor of mortality in hemodialysis patients.
Simic-Ogrizovic S; Dopsaj V; Bogavac-Stanojevic N; Obradovic I; Stosovic M; Radovic M
Tohoku J Exp Med; 2009 Oct; 219(2):121-7. PubMed ID: 19776529
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A: a novel serum marker for the detection of systemic inflammatory response in cystitis.
Lannergard A; Friman G; Larsson A
J Urol; 2003 Sep; 170(3):804-6. PubMed ID: 12913703
[TBL] [Abstract][Full Text] [Related]
13. Determinants of albumin concentration in hemodialysis patients.
Kaysen GA; Stevenson FT; Depner TA
Am J Kidney Dis; 1997 May; 29(5):658-68. PubMed ID: 9159298
[TBL] [Abstract][Full Text] [Related]
14. Significance of albumin and C-reactive protein variations in 300 end stage renal disease patients in Tehran University of Medical Sciences Hospitals during year 2010.
Dashti N; Einollahi N; Nabatchian F; Moradi Sarabi M; Zarebavani M
Acta Med Iran; 2012; 50(3):197-202. PubMed ID: 22418989
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.
Maier W; Altwegg LA; Corti R; Gay S; Hersberger M; Maly FE; Sütsch G; Roffi M; Neidhart M; Eberli FR; Tanner FC; Gobbi S; von Eckardstein A; Lüscher TF
Circulation; 2005 Mar; 111(11):1355-61. PubMed ID: 15753219
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.
Panichi V; Maggiore U; Taccola D; Migliori M; Rizza GM; Consani C; Bertini A; Sposini S; Perez-Garcia R; Rindi P; Palla R; Tetta C
Nephrol Dial Transplant; 2004 May; 19(5):1154-60. PubMed ID: 14993508
[TBL] [Abstract][Full Text] [Related]
17. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes.
Memoli B; Minutolo R; Bisesti V; Postiglione L; Conti A; Marzano L; Capuano A; Andreucci M; Balletta MM; Guida B; Tetta C;
Am J Kidney Dis; 2002 Feb; 39(2):266-73. PubMed ID: 11840366
[TBL] [Abstract][Full Text] [Related]
18. The variability and accurate assessment of microinflammation in haemodialysis patients.
Tsirpanlis G; Bagos P; Ioannou D; Bleta A; Marinou I; Lagouranis A; Chatzipanagiotou S; Nicolaou C
Nephrol Dial Transplant; 2004 Jan; 19(1):150-7. PubMed ID: 14671050
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein as an outcome predictor for maintenance hemodialysis patients.
Owen WF; Lowrie EG
Kidney Int; 1998 Aug; 54(2):627-36. PubMed ID: 9690231
[TBL] [Abstract][Full Text] [Related]
20. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis.
Enia G; Panuccio V; Cutrupi S; Pizzini P; Tripepi G; Mallamaci F; Zoccali C
Nephrol Dial Transplant; 2007 Feb; 22(2):538-44. PubMed ID: 17082213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
